We welcome various forms of collaboration:

1. Technology Licensing: License our patented technologies to partners for commercial development
2. Joint R&D: Collaborate with universities, research institutes, and pharma companies on new drug projects
3. CDMO Services: Provide full-process services from process development to manufacturing
4. Investment Cooperation: Open financing opportunities to jointly advance project development

Please contact our BD team at: partner@huayu-biopharma.com

Founded in 2015, Hangzhou Huayu Biopharma Co., Ltd. is a high-tech enterprise focused on innovative biopharmaceutical R&D. Our business covers core areas including cell therapy, recombinant protein drugs, monoclonal antibody drugs, and innovative vaccines.

We have a world-class R&D team composed of returned PhDs and senior industry experts, with a provincial-level enterprise technology center and postdoctoral research station. Guided by the philosophy of "Innovation Ignites Life, Technology Safeguards Health," we are dedicated to translating cutting-edge scientific achievements into patient-benefiting therapies.

We hold the following main certifications and qualifications:

• National High-T Enterprise Certification
• Provincial-Level Enterprise Technology Center
• Postdoctoral Research Workstation
• ISO9001 Quality Management System Certification
• 50+ National Invention Patents Granted
• Multiple products in IND filing stage

The ordering process is as follows:

1. Submit your request through our Contact Us page
2. Our sales team will contact you within 24 hours
3. Confirm product specifications, quantity, and delivery timeline
4. Sign contract and arrange production/shipping

For urgent orders, please call directly: +86 0571-8888 8888

Our product portfolio mainly includes:

• Cell Therapy Products: CAR-T, TCR-T and other immune cell therapy technologies
• Recombinant Protein Drugs: High-activity cytokines, growth factors, etc.
• Monoclonal Antibodies: Therapeutic mAbs, bispecific antibodies, ADC drugs
• Innovative Vaccines: Cancer vaccines, preventive vaccines

Multiple candidate drugs are currently in preclinical or clinical trial stages.

We have established a comprehensive quality management system:

• GMP-compliant production facilities and QC laboratories
• ISO9001 quality management system certification
• Rigorous quality testing and release procedures for each batch
• Complete traceability system ensuring product quality tracking
• Regular inspections and audits by regulatory authorities